JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Activity Details


132 *	Mon, 8/1/2011, 8:30 AM - 10:20 AM	CC-C224
Multiplicity and Multiple Comparisons 1 — Contributed Papers
Biopharmaceutical Section
Chair(s): Yong Zhang, Novartis Oncology
8:35 AM	Comparison of Gatekeeping and Other Testing Methods for Identifying Superior Drug Combinations in Bi-Factorial Designs with Isotonic Parameters — Julia Soulakova, University of Nebraska at Lincoln
8:50 AM	Asymptotically Efficient Sequential Tests of Multiple Hypotheses — Shyamal Krishna De, The University of Texas at Dallas ; Michael Baron, The University of Texas at Dallas
9:05 AM	Multiplicity Adjustment Considerations for Multiple Treatments (Doses) and Endpoints — Nancy Ying Liu, Merck & Co., Inc. ; Jing Li, Merck & Co., Inc. ; Ziliang Li, Merck & Co., Inc. ; Amarjot Kaur, Merck & Co., Inc.
9:20 AM	Development of Multiple Testing Strategies in Confirmatory Clinical Trials — Brian A. Millen, Eli Lilly and Company ; Alex Dmitrienko, Eli Lilly and Company
9:35 AM	Multiple Comparisons for Partial Covariance Matrices of Two Treatment Groups in Clinical Trial — Yoshiomi Nakazuru, Tokyo University of Science ; Takashi Seo, Tokyo University of Science
9:50 AM	A Consistency-Adjusted Strategy for Testing Alternative Endpoints in a Clinical Trial — Mohamed A. Alosh, U.S. Food and Drug Administration
10:05 AM	Multiplicity Issues in Clinical Trials with Co-Primary Endpoints, Secondary Endpoints, and Multiple Dose Comparisons — Haiyan Xu, Johnson & Johnson Pharmaceutical R&D, LLC ; Pilar Lim, Johnson & Johnson Pharmaceutical R&D, LLC

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.